Compare ATI & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATI | KVUE |
|---|---|---|
| Founded | 1960 | 2022 |
| Country | United States | United States |
| Employees | 7600 | N/A |
| Industry | Steel/Iron Ore | Specialty Chemicals |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.7B | 34.2B |
| IPO Year | 1996 | 2023 |
| Metric | ATI | KVUE |
|---|---|---|
| Price | $185.63 | $17.96 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 11 |
| Target Price | ★ $153.75 | $19.45 |
| AVG Volume (30 Days) | 1.7M | ★ 24.6M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 4.82% |
| EPS Growth | 11.76 | ★ 40.74 |
| EPS | ★ 1.94 | 0.48 |
| Revenue | $4,043,500,000.00 | ★ $15,124,000,000.00 |
| Revenue This Year | $9.52 | $4.85 |
| Revenue Next Year | $9.02 | $2.63 |
| P/E Ratio | $94.66 | ★ $37.48 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $75.08 | $14.02 |
| 52 Week High | $243.57 | $20.13 |
| Indicator | ATI | KVUE |
|---|---|---|
| Relative Strength Index (RSI) | 35.02 | 37.25 |
| Support Level | $176.83 | $17.86 |
| Resistance Level | $204.80 | $19.15 |
| Average True Range (ATR) | 8.07 | 0.31 |
| MACD | -2.79 | -0.07 |
| Stochastic Oscillator | 17.22 | 21.77 |
ATI Inc supplies specialty metals to various end markets, including aerospace and defense, oil and gas, automotive, and electrical energy, among many others. The company's operating segment includes High-Performance Materials and Components and Advanced Alloys and Solutions. The majority of revenue is from the High-Performance Materials segment. The High-Performance Materials segment is focused on a wide range of high-performance specialty materials, parts, and components for several the majority of end markets, including the aerospace & defense, medical, and energy markets. Geographically, it operates in the United States, China, the United Kingdom, Germany, France, Canada, and Others, the majority is from the United States.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.